Virtu Financial LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Sep 17, 2021	SELL	$23.12 - $29.91 $306,617 - $396,666	-13,262 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$14.69 - $42.57 $194,818 - $564,563	13,262 New	13,262 $341,000
Q4 2018 Jan 16, 2019	SELL	$16.21 - $24.06 $158,128 - $234,705	-9,755 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$8.0 - $22.11 $78,040 - $215,683	9,755 New	9,755 $216,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.